Atlas Trials

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

Clinical trial NCT01754714 · COMPLETED

Trial details

NCT number
NCT01754714
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non Alcoholic Fatty Liver Disease
Start date
2012-12-01
Primary completion
2014-09-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.